Concepedia

Heidi L. Galonek

HL

Statistics

Publications

4

Citations

2.4K

H-Index

4

Active since

1999

Affiliations

Tris Pharma (United States)(Current)

Heidi L. Galonek is an author at Tris Pharma (United States) specializing in life sciences, molecular biology, and sirtuin 1 regulation.

Publications per year

1999–2009

4

Publications

4

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Jill C. Milne, Philip Lambert, Simon Schenk et al. · Nature · 2007 · 1.7K citations · Full text

, , +14

Loss of imprinting of a paternally expressed transcript, with antisense orientation to K <sub>V</sub> LQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting

Maxwell P. Lee, Michael R. DeBaun, Kohzoh Mitsuya et al. · Proceedings of the National Academy of Sciences · 1999 · 358 citations

, , +15

Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo

J. Joshua Smith, Renée Deehan Kenney, David Gagné et al. · BMC Systems Biology · 2009 · 211 citations · Full text

, , +17

Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3

Lei Jin, Heidi L. Galonek, Kristine Israelian et al. · Protein Science · 2009 · 150 citations · Full text

, , +14

1–4 of 4